Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Monitoring Radiotherapeutic Response in Prostate Cancer Patients Using High Throughput FTIR Spectroscopy of Liquid Biopsies.

Medipally DKR, Nguyen TNQ, Bryant J, Untereiner V, Sockalingum GD, Cullen D, Noone E, Bradshaw S, Finn M, Dunne M, Shannon AM, Armstrong J, Lyng FM, Meade AD.

Cancers (Basel). 2019 Jul 2;11(7). pii: E925. doi: 10.3390/cancers11070925.

2.

Prediction of DNA damage and G2 chromosomal radio-sensitivity ex vivo in peripheral blood mononuclear cells with label-free Raman micro-spectroscopy.

Meade AD, Maguire A, Bryant J, Cullen D, Medipally D, White L, McClean B, Shields L, Armstrong J, Dunne M, Noone E, Bradshaw S, Finn M, Shannon AM, Howe O, Lyng FM.

Int J Radiat Biol. 2019 Jan;95(1):44-53. doi: 10.1080/09553002.2018.1451006. Epub 2018 Mar 29.

PMID:
29528761
3.

Liver lacerations as a complication of CPR during pregnancy.

Cox TR, Crimmins SD, Shannon AM, Atkins KL, Tesoriero R, Malinow AM.

Resuscitation. 2018 Jan;122:121-125. doi: 10.1016/j.resuscitation.2017.10.027. Epub 2017 Oct 31.

PMID:
29097198
4.

Patient Perception of Value in Bundled Payments for Total Joint Arthroplasty.

Schwartz AJ, Fraser JF, Shannon AM, Jackson NT, Raghu TS.

J Arthroplasty. 2016 Dec;31(12):2696-2699. doi: 10.1016/j.arth.2016.05.050. Epub 2016 May 31.

PMID:
27378636
5.

Examining changes in [18 F]FDG and [18 F]FLT uptake in U87-MG glioma xenografts as early response biomarkers to treatment with the dual mTOR1/2 inhibitor AZD8055.

Keen HG, Ricketts SA, Maynard J, Logie A, Odedra R, Shannon AM, Wedge SR, Guichard SM.

Mol Imaging Biol. 2014 Jun;16(3):421-30. doi: 10.1007/s11307-013-0705-0.

PMID:
24249640
6.

Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy.

Morrissey B, O'Shea C, Armstrong J, Rooney C, Staunton L, Sheehan M, Shannon AM, Pennington SR.

Proteomics Clin Appl. 2013 Jun;7(5-6):316-26. doi: 10.1002/prca.201300004.

PMID:
23670859
7.

The mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) enhances the radiation responsiveness of lung and colorectal tumor xenografts.

Shannon AM, Telfer BA, Smith PD, Babur M, Logie A, Wilkinson RW, Debray C, Stratford IJ, Williams KJ, Wedge SR.

Clin Cancer Res. 2009 Nov 1;15(21):6619-29. doi: 10.1158/1078-0432.CCR-08-2958. Epub 2009 Oct 20.

8.

Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts.

Williams KJ, Telfer BA, Shannon AM, Babur M, Stratford IJ, Wedge SR.

Br J Radiol. 2008 Oct;81 Spec No 1:S21-7. doi: 10.1259/bjr/59853976.

PMID:
18819995
9.

Antiangiogenics and radiotherapy.

Shannon AM, Williams KJ.

J Pharm Pharmacol. 2008 Aug;60(8):1029-36. doi: 10.1211/jpp.60.8.0009. Review.

PMID:
18644195
10.

Combining radiotherapy with AZD2171, a potent inhibitor of vascular endothelial growth factor signaling: pathophysiologic effects and therapeutic benefit.

Williams KJ, Telfer BA, Shannon AM, Babur M, Stratford IJ, Wedge SR.

Mol Cancer Ther. 2007 Feb;6(2):599-606.

11.

Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression.

O'Donnell JL, Joyce MR, Shannon AM, Harmey J, Geraghty J, Bouchier-Hayes D.

Cancer Treat Rev. 2006 Oct;32(6):407-16. Epub 2006 Aug 4. Review.

PMID:
16889900
12.
13.

Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.

Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D.

Cancer Treat Rev. 2003 Aug;29(4):297-307. Review.

PMID:
12927570
14.

Characterizations of advocacy by practicing nurses.

Chafey K, Rhea M, Shannon AM, Spencer S.

J Prof Nurs. 1998 Jan-Feb;14(1):43-52.

PMID:
9473903
15.

UKCC fuels HIV/AIDS controversy.

Shannon AM.

Br J Nurs. 1993 May 27-Jun 9;2(10):507. No abstract available.

PMID:
8324345
16.

Clinical value of microbiological investigations in general practice.

Tompkins DS, Shannon AM.

Br J Gen Pract. 1993 Apr;43(369):155-8.

17.

The NLN accreditation study: its relation to the CBHDP accreditation process.

Shannon AM.

NLN Publ. 1983;(15-1923):11-25. No abstract available.

PMID:
6553228
18.

Health policy and research: revisited.

Shannon AM.

West J Nurs Res. 1981 Summer;3(3):79-82. No abstract available.

PMID:
6914101
19.

Pseudofolliculitis due to preoperative shaving.

Tkach JR, Shannon AM, Beastrom R.

AORN J. 1979 Nov;30(5):881-4. No abstract available.

PMID:
259001
20.

Response to proposed strategies in application of a model for decision making.

Shannon AM.

NLN Publ. 1978;(15-1719):57-9. No abstract available.

PMID:
247297
21.

Replication of study regarding perception of nonverbal behavior.

Shannon AM.

ANA Publ. 1975;(PMH-2):50-8. No abstract available.

PMID:
1045878
22.

Critique of "Supportive measures for relatives of the fatally ill".

Shannon AM.

Commun Nurs Res. 1973 Dec;6:129-35. No abstract available.

PMID:
4499878
23.

Facial expression of emotion: recognition patterns in schizophrenics and depressives.

Shannon AM.

Nurs Res Conf. 1971 Mar;7:131-46. No abstract available.

PMID:
5210567
24.

Co-therapy as an egalitarian relationship.

Getty C, Shannon AM.

Am J Nurs. 1969 Apr;69(4):767-71. No abstract available.

PMID:
5191177
25.

Nurses as co-therapists in a family-therapy setting.

Getty C, Shannon AM.

Perspect Psychiatr Care. 1967 Jan-Feb;5(1):38-46. No abstract available.

PMID:
5180853

Supplemental Content

Loading ...
Support Center